Effects of Arabinoxylan-Oligosaccharides Compared to Other Prebiotics in Healthy Subjects

The purpose of the study is to evaluate the effects of arabinoxylan-oligosaccharides (AXOS) on the colonic metabolism and microbial composition, and to compare these effects with the reference prebiotic fructo-oligosaccharide enriched inulin.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Department of Gastrointestinal Research, Laboratory Digestion and Absorption

Leuven, 3000, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

healthy
18-45 years
regular eating pattern

Exclusion criteria

gastrointestinal complaints
antibiotic intake
medication influencing gut transit or microbiota
abdominal surgery
pregnancy

Treatment and study plan

FOS-IN

Dietary Supplement

prebiotic fructo-oligosaccharide enriched inulin

intake period: 2 weeks, 1.25 or 2.50g every morning and evening

Other names: Synergy1, Orafti, Tienen

AXOS

Dietary Supplement

arabinoxylan-oligosaccharides (AXOS)

intake period: 2 weeks, 1.25 or 2.50g every morning and evening

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Registry information

Official study title

Effects of Arabinoxylan-Oligosaccharides on Colonic Metabolism and Microbial Composition Compared to Other Prebiotics in Healthy Subjects

Important dates

Study start: 2006
Study completion: 2007
First posted: Feb 27, 2009
Registry last updated: Feb 27, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed